Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge assisted Altor Fund III in connection with sale of shares in CTEK AB (publ)
Mandate

Vinge assisted Altor Fund III in connection with sale of shares in CTEK AB (publ)

March 31, 2022 Capital Markets and Public M&A Automotive, Mobility and Electrification

Vinge assisted Altor Fund III GP Limited (”Altor”) in connection with the sale of shares in CTEK AB (publ) (”CTEK”) through an accelerated bookbuilding process. Altor sold shares to a value of SEK 621 million and holds approximately 10 per cent of the shares in CTEK after the sale.

Vinge’s team consisted of David Andersson and Isabell Anstrin.

 

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026